Gastroenterology and Hepatology From Bed to Bench最新文献

筛选
英文 中文
The prevalence of latent/chronic infection in liver transplant candidates in Taleghani Hospital of Tehran, Iran, from 2020 until 2021. 2020年至2021年,伊朗德黑兰Taleghani医院肝移植候选者中潜伏/慢性感染的患病率
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i1.2664
Amirhassan Rabbani, Hesameddin Eghlimi, Mina Khoshkbarforoushan, Mana Baziboroun
{"title":"The prevalence of latent/chronic infection in liver transplant candidates in Taleghani Hospital of Tehran, Iran, from 2020 until 2021.","authors":"Amirhassan Rabbani,&nbsp;Hesameddin Eghlimi,&nbsp;Mina Khoshkbarforoushan,&nbsp;Mana Baziboroun","doi":"10.22037/ghfbb.v16i1.2664","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i1.2664","url":null,"abstract":"<p><strong>Aim: </strong>The present study aimed to study the prevalence of various latent infections in pre-transplanted patients.</p><p><strong>Background: </strong>Due to chronic immunosuppressive therapy, patients receiving organ transplants are at risk for reactivation of various infections. Due to the complications in the course of diagnosing and treating the post-transplant infection, screening transplant recipients and donors is vital.</p><p><strong>Methods: </strong>This retrospective cohort study was performed between March 2020 and 2021. A total of 193 patients receiving a liver transplant in Taleghani Hospital, Tehran, Iran were enrolled.</p><p><strong>Results: </strong>One-hundred and three (53.4%) patients were men, with an average age of 48.4 ± 13.3 years. Among viruses, 177 (91.7%) patients had a positive IgG titer for CMV. Anti-EBV IgG was positive in 169 (87.6%) patients. One-hundred and seventy-five (90.7%) patients had a positive IgG titer for the VZV. One-hundred and sixty-six (86.0%) cases had positive IgG anti-HSV antibodies. According to our findings, none of the patients were infected with HIV, but 9 (4.7%) cases and 141 (73.1%) had positive anti-HCV and anti-HAV IgG antibodies, respectively. HBV surface (HBs) antigen was also reported positive in 17 (8.8%) patients, while the HBs antibody was positive in 29 (15.0%) patients.</p><p><strong>Conclusion: </strong>In our study, most of the patients had positive serology for latent viral infections such as CMV, EBV, VZV, and HSV, but the prevalence of latent tuberculosis and viral hepatitis was low among transplant candidates.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 1","pages":"478-485"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/c2/GHFBB-16-478.PMC10105496.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9380018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The SW480 cell line, overexpressing PIWIL2 gene, maintains the expression of stemness and proliferation genes in the mice xenografts. 过表达PIWIL2基因的SW480细胞系在小鼠异种移植物中保持了干细胞和增殖基因的表达。
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i1.2661
Roya Kishani Farahani, Ehsan Nazemalhosseini Mojarad, Hamid Reza Soleimanpour-Lichaei
{"title":"The SW480 cell line, overexpressing PIWIL2 gene, maintains the expression of stemness and proliferation genes in the mice xenografts.","authors":"Roya Kishani Farahani,&nbsp;Ehsan Nazemalhosseini Mojarad,&nbsp;Hamid Reza Soleimanpour-Lichaei","doi":"10.22037/ghfbb.v16i1.2661","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i1.2661","url":null,"abstract":"<p><strong>Aim: </strong>This study aims to confirm previous fundamental in vitro findings about the PIWIL2 gene by investigating the effects of its overexpression on cell cycle, proliferation, apoptosis, and stem cell expression markers in colorectal cancer cells (CRC cells) at in vivo level.</p><p><strong>Background: </strong>PIWIL2 has a critical role in maintaining cellular stemness and proliferation. PIWIL2 is an oncogene whose expression in CRC is associated with the occurrence, metastasis, and poor prognosis.</p><p><strong>Methods: </strong>SW480 cells harboring expression vectors with/without PIWIL2 were cultured and inoculated in BALB/c nude mice. Tumor formation and growth were monitored every 3 days. On the 28th day after inoculation, the tumors were harvested for their total RNA extraction, and the expression profiling of the candidate genes was performed by Real-time PCR.</p><p><strong>Results: </strong>Our results for the expression profiling of the xenografted tumors showed a significant increase in the expression of cancer stem cell markers, including CD24, CD133, and pluripotency marker SOX2 in the PIWIL2 over-expressing xenografts, compared to the control cell line. Moreover, PIWIL2 dramatically promoted the anti-apoptotic pathway by inducing STAT3 and BCL2-L1 genes in the PIWIL2 over-expressing xenografts, along with the up-regulation of Cyclin D1 and Ki-67 genes.</p><p><strong>Conclusion: </strong>This research supports our prior in vitro findings, highlighting the critical role that PIWIL2 plays in the development of CRC and its substantial promise as a leading candidate for CRC-targeted therapy.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 1","pages":"492-498"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/14/GHFBB-16-492.PMC10105508.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9679455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and evaluation of a semi-nested PCR technique for amplification and determination of different surface gene variation patterns in patients with chronic HBV infection: development of an amplification method for HBV S gene. 用于慢性HBV感染患者不同表面基因变异模式扩增和测定的半巢式PCR技术的开发和评价:HBV S基因扩增方法的开发。
Fedra Mokhtari, Hami Kaboosi, Seyed Reza Mohebbi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali
{"title":"Development and evaluation of a semi-nested PCR technique for amplification and determination of different surface gene variation patterns in patients with chronic HBV infection: development of an amplification method for HBV S gene.","authors":"Fedra Mokhtari,&nbsp;Hami Kaboosi,&nbsp;Seyed Reza Mohebbi,&nbsp;Hamid Asadzadeh Aghdaei,&nbsp;Mohammad Reza Zali","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>Development of an amplification method for further investigation of HBV S gene variation patterns.</p><p><strong>Background: </strong>Pre-S/S variants in patients with chronic HBV infection may contribute to the progression of liver damage and Hepatocellular carcinoma (HCC).</p><p><strong>Methods: </strong>This study was performed on ten patients with chronic HBV infection. Viral DNA was extracted from patient's plasma, primer design was performed, and a semi-nested PCR method was set up to amplify the pre-S/S region of HBV genome. Subsequently, sequencing was performed to analyze the variants of this region.</p><p><strong>Results: </strong>In the current study, the semi-nested PCR method was successfully set up, and types of variation in the studied samples were investigated.</p><p><strong>Conclusion: </strong>Pre-S/S variants should be routinely determined in HBV carriers to help identify individuals who may be at a high risk of less favorable liver disease progression. This study showed that the technique could accurately amplify the pre-S/S region, and the product can be successfully used for variation detection by direct sequencing.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 1","pages":"520-523"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f5/ad/GHFBB-16-520.PMC10105500.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9679460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transient non-coeliac gluten sensitivity (NCGS) with markedly reduced villous height/crypt depth ratio. 瞬态非乳糜泻谷蛋白敏感性(NCGS),绒毛高度/隐窝深度比显著降低。
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2755
Charlotte Williams, Nicole Smith, Kamran Rostami
{"title":"Transient non-coeliac gluten sensitivity (NCGS) with markedly reduced villous height/crypt depth ratio.","authors":"Charlotte Williams,&nbsp;Nicole Smith,&nbsp;Kamran Rostami","doi":"10.22037/ghfbb.v16i2.2755","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2755","url":null,"abstract":"<p><p>There is no confident evidence in the current literature to show or demonstrate that non-coeliac gluten sensitivity (NCGS) exclusively presents with mild or nearly normal duodenal mucosal abnormality. Gluten sensitive patients with negative serology and severe mucosal changes are labelled with the term seronegative coeliac disease (SNCS). There might be at least some overlap between NCGS and SNCD. Transient gluten sensitivity with severe mucosal changes without CD have been previously reported like in our case.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 2","pages":"222-224"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/a3/GHFBB-16-222.PMC10404823.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10559740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No-biopsy diagnostic approach to coeliac disease. 乳糜泻的无活检诊断方法。
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2706
Geoffrey Holmes
{"title":"No-biopsy diagnostic approach to coeliac disease.","authors":"Geoffrey Holmes","doi":"10.22037/ghfbb.v16i2.2706","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2706","url":null,"abstract":"<p><p>This brief review outlines contributions that Michael Marsh and others made to understanding the structure and function of the upper small bowel mucosa and the formation of abnormalities that occur in coeliac disease (CD). He introduced his classification of lesions 30 years ago that has been widely adopted. The development and use of serological tests to screen for and diagnose CD in children and adults without the need for a small bowel biopsy in a considerable proportion is also recognised and will gain traction.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 2","pages":"112-117"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/82/GHFBB-16-112.PMC10404819.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10559743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of acupressure on intestinal function in patients with coronary artery bypass graft surgery: a randomized clinical trial. 穴位按压对冠状动脉搭桥术患者肠道功能的影响:一项随机临床试验。
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2720
Fatemeh Khan-Mohammadi, Hedayat Jafari, Masoumeh Bagheri-Nesami, Mahmood Moosazadeh, Mahsa Kamali, Nadali Esmaeili-Ahangarkelai, Kamran Quds
{"title":"Effects of acupressure on intestinal function in patients with coronary artery bypass graft surgery: a randomized clinical trial.","authors":"Fatemeh Khan-Mohammadi,&nbsp;Hedayat Jafari,&nbsp;Masoumeh Bagheri-Nesami,&nbsp;Mahmood Moosazadeh,&nbsp;Mahsa Kamali,&nbsp;Nadali Esmaeili-Ahangarkelai,&nbsp;Kamran Quds","doi":"10.22037/ghfbb.v16i2.2720","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2720","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to determine the effects of acupressure on the intestinal function of patients undergoing Coronary Artery Bypass Graft (CABG) surgery.</p><p><strong>Background: </strong>Studies indicated that cardiovascular patients are prone to constipation. Acupressure is one of the therapeutic and palliative approaches that can be used by doctors, nurses, and even patients themselves.</p><p><strong>Methods: </strong>The present three-group randomized clinical trial study was conducted on 90 patients undergoing CABG surgery. In the intervention group, 48 hours after surgery the patients received acupressure points LI4 and ST25 twice a day (10 am and 6 pm) for three sequential days. In the sham group, the patients received acupressure at a 1.5 cm distance from the LI4-ST25 points, and the patients in the control group received only the usual care. This research used a demographic and medical information questionnaire, Rome IV scale, Bristol stool scale, symptom registration checklist, and daily excretion assessment checklist. The intestinal function indices were completed 24 hours after surgery (before intervention), 48, 72, 96, and 120 hours after surgery.</p><p><strong>Results: </strong>All three intervention, sham, and control groups were without defecation in 24 hours (before intervention) and 48 hours after surgery. There was a significant difference between the three intervention, sham, and control groups in the number of stools after 72 hours, 96 hours, and 120 hours after the intervention (p<0.001). Also, a significant difference was observed among the three groups in terms of stool consistency 96 hours after the start of the intervention (p=0.032) and 120 hours after the start of the intervention (p<0.001).</p><p><strong>Conclusion: </strong>The results showed that patients had a significant improvement in the number of bowel movements and stool consistency in the intervention group. In acute conditions, acupressure on LI4-ST25 points can positively affect intestinal function when patients are hospitalized in the intensive care unit.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"282-291"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/c2/GHFBB-16-282.PMC10520391.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41112061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychometric properties of Persian version of irritable bowel syndrome- behavioral responses questionnaire (IBS-BRQ). 波斯版肠易激综合征的心理测量特性-行为反应问卷(IBS-BRQ)。
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2440
Amrollah Ebrahimi, Mohammad Forghani, Masoudeh Bababkhanian, Mehdi Ebrahimi, Peyman Adibi Sedeh
{"title":"Psychometric properties of Persian version of irritable bowel syndrome- behavioral responses questionnaire (IBS-BRQ).","authors":"Amrollah Ebrahimi,&nbsp;Mohammad Forghani,&nbsp;Masoudeh Bababkhanian,&nbsp;Mehdi Ebrahimi,&nbsp;Peyman Adibi Sedeh","doi":"10.22037/ghfbb.v16i2.2440","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2440","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to determine the psychometric properties of Persian version of Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ).</p><p><strong>Background: </strong>In addition to somatic symptoms and complaints, patients with irritable bowel syndrome have specific dysfunctional behaviors that lead to disease persistence and functional disturbance.</p><p><strong>Methods: </strong>Participants included 170 patients with irritable bowel syndrome, who were diagnosed based on ROM-IV criteria and selected from patients referring to the Gastrointestinal Disorders Clinic, as well as 100 persons from the general population in Isfahan in 2020. Both groups completed the 26-item Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ). Also, questionnaires including the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS), Irritable Bowel Syndrome-Quality of Life IBS-QOL, Illness Perception Questionnaire (IPQ-R), Irritable Bowel Syndrome-Patient Satisfaction (IBS-SAT), Hope Scale, Interpersonal Forgiveness Inventory (IFI), and Dysfunctional Attitude Scale- 26-item (DAS-26) were completed to determine the validity of IBS-BRQ. Tests of internal consistency, principal components analyses (PCAs), differentiation analysis, and correlation were used to determine its reliability, along with criterion and construct validity.</p><p><strong>Results: </strong>IBS-BRQ was valid and reliable in both groups with a high degree of internal consistency. Cronbach's alpha was obtained in the sample of patients with IBS and the total sample of participants 0.87 and 0.95 respectively. This scale differentiated significantly between IBS patients and non-patients (p<.001). The criterion validity was high as evidenced by a high correlation with DAS-26 (r=0.53, p<0.001), IBS-QOL (r=0.76, p<0.001), IBS-SSS (r=0.44, p<0.001), IPQ-R (r=0.56, p<0.001), and reverse correlation with IFI (r=-0.031, p<0.001), IBS-SAT (r=-0.23, p<0.001), and HOPE (r=-0.49, p<0.001).</p><p><strong>Conclusion: </strong>The Persian version of the IBS-BRQ proved to be a well-defined behavioral response measure in IBS patients with high validity and reliability, making it a suitable measure to be used in future IBS clinical research in Iran.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"326-335"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/bf/GHFBB-16-326.PMC10520395.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41117107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autologous platelet-rich-plasma injection and platelet-rich fibrin glue interposition for treatment of anal fistula resistant to surgery. 自体富含血小板的血浆注射和富含血小板的纤维蛋白胶介入治疗对手术有抵抗力的肛瘘。
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2719
Abbas Abdollahi, Elaheh Emadi, Daryoush Hamidi Alamdari
{"title":"Autologous platelet-rich-plasma injection and platelet-rich fibrin glue interposition for treatment of anal fistula resistant to surgery.","authors":"Abbas Abdollahi,&nbsp;Elaheh Emadi,&nbsp;Daryoush Hamidi Alamdari","doi":"10.22037/ghfbb.v16i2.2719","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2719","url":null,"abstract":"<p><strong>Aim: </strong>The current study purposed to evaluate the autologous platelet-rich plasma (PRP), and platelet-rich fibrin glue (PRFG) effect on the treatment of complex, and recalcitrant anal fistula (AF) which was not cured by several surgeries.</p><p><strong>Background: </strong>AF has remained one of difficult challenges for centuries. Surgery is the common treatment method for it, but the risk of fecal incontinence and recurrence is still a distressing complication for patients and surgeons. New procedures were published in the scientific literature, each with advantages and disadvantages. According to reports, an effective therapy option is the autologous fibrin glue that is rich in platelets.</p><p><strong>Methods: </strong>Autologous PRP and PRFG were prepared from 10 patients' own blood. The surgeon curetted the tract of anal fistula for the deepithelialisation till hemorrhage occurred; PRP was injected around the fistula into the tissue, and PRFG was interpositioned in the tract. Age, number of previous surgeries, complications, number of PRP and PRFG administrations, and duration of halting the discharge were among the information gathered. Patients were followed up between 10 months to 84 months after treatment.</p><p><strong>Results: </strong>No complications were observed during and after the injection. During the period of follow-up, AF leakage was stopped for 6 patients, but not for 4 patients.</p><p><strong>Conclusion: </strong>Since autologous PRP injection, and PRFG interposition is a safe, effective, and minimally invasive procedure for resistant AF to surgeries; it can be used, along with surgery to increase the healing rate of complex anal fistula.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"292-296"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/d5/GHFBB-16-292.PMC10520388.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41117170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the influence of environmental risk factors on inflammatory bowel diseases: a case-control study. 评估环境危险因素对炎症性肠病的影响:一项病例对照研究。
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2576
Rahil Riahi, Saeed Abdi, Sara Ashtari, Habib Malekpour
{"title":"Evaluating the influence of environmental risk factors on inflammatory bowel diseases: a case-control study.","authors":"Rahil Riahi,&nbsp;Saeed Abdi,&nbsp;Sara Ashtari,&nbsp;Habib Malekpour","doi":"10.22037/ghfbb.v16i2.2576","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2576","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to examine the environmental factors associated in Iranian patients with inflammatory bowel disease (IBD).</p><p><strong>Background: </strong>The role of environmental factors in the development of IBD remains uncertain.</p><p><strong>Methods: </strong>In this case-control study, the patients with IBD referred to the Taleghani Hospital, Tehran, Iran, were recruited from 2017 to 2019. Controls were matched by sex. Data were collected using the designed questionnaire and also valid questionnaire such Pittsburgh Sleep Quality Index (PSQI) and Hospital Anxiety and Depression Scale (HADS) for sleep quality and anxiety/depression, respectively. Conditional logistic regression models were used to estimate adjusted odds ratios (ORs).</p><p><strong>Results: </strong>The study population included 200 individuals: 100 (50%) IBD patients and 100 (50%) controls. Age under 50, marital status, sleep difficulties, vitamin D insufficiency, anxiety/depression, dietary fiber deficit, post-menopausal hormone treatment, oral contraceptives, and antibiotics were all prognostic factors for IBD on the univariate analysis (P< 0.005). In multivariate analysis, the risk of IBD was significantly increased with 50 years (OR: 6.699, 95%CI: 3.271-8.662, P=0.017), abnormal sleep status (OR: 6.383, 95%CI: 3.389-7.19, P=0.001), and using oral contraceptive (OR: 7.426, 95%CI: 5.327-9.865, P=0.001). However, the risk of IBD was significantly decreased with older age (OR: 0.795, 95%CI: 0.697-0.907, P=0.001) and married status (OR: 0.008, 95%CI: 0.001-0.438, P=0.018).</p><p><strong>Conclusion: </strong>Data suggest that the environmental factors play a significant role in the etiology of IBD and probably on the disease course. While the evidence for some factors is strong, many factors require further supportive data.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"307-318"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/b0/GHFBB-16-307.PMC10520386.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41133608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival of gastric cancer patients in Iran: a systematic review and meta-analysis. 伊朗癌症患者生存率的系统回顾和荟萃分析。
Gastroenterology and Hepatology From Bed to Bench Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2674
Fargol Farahmandi, Mohammad-Mahdi Salarabedi, Parynaz Parhizgar, Swetha Variyath, Nabeel Al-Yateem, Syed Azizur Rahman, Amina Al-Marzouqi, Saeed Hashemi Nazari, Alireza Mosavi Jarrahi
{"title":"Survival of gastric cancer patients in Iran: a systematic review and meta-analysis.","authors":"Fargol Farahmandi,&nbsp;Mohammad-Mahdi Salarabedi,&nbsp;Parynaz Parhizgar,&nbsp;Swetha Variyath,&nbsp;Nabeel Al-Yateem,&nbsp;Syed Azizur Rahman,&nbsp;Amina Al-Marzouqi,&nbsp;Saeed Hashemi Nazari,&nbsp;Alireza Mosavi Jarrahi","doi":"10.22037/ghfbb.v16i2.2674","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2674","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to estimate the survival rates among Iranian gastric cancer patients and to evaluate if the survival has improved during the last three decades.</p><p><strong>Background: </strong>Gastric cancer is one of the most common cancers in Iran with high mortality.</p><p><strong>Methods: </strong>A systematic review and meta-analysis of all published studies addressing gastric cancer survival in Iran was performed. International databases of Scopus, Web of Science, PubMed, and Iranian databases were included in the study. The study included databases from their inception till February 2022. Due to the inherent heterogeneity, we used a random effect model to pool the survivals in three categories of one, three, and five-year survivals.</p><p><strong>Results: </strong>Thirty-three studies with total cases of 17,207 were included in the study. The overall (pooled) one, three, and five-year survivals were estimated as 58.9% (95% CI: 0.52, 0.66), 29.9% (95% CI: 0.25, 0.35), and 18.2% (95% CI: 0.15, 0.23), respectively. Results of subgroup analysis for the calendar years of study showed that the one, three, and five-year survival rates increased during the last three decades but the results were not statistically significant. There was the disparity in survival based on geographic distribution.</p><p><strong>Conclusion: </strong>The results of our study which has pooled many studies for a long period of time clearly indicate that the survival rates of gastric cancer patients have improved. As the improvement of survival may be due to many factors, more studies is needed to understand the dynamic behind this improvement.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"245-258"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/7b/GHFBB-16-245.PMC10520396.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41148856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信